A study for a 34 year old woman who takes Rexulti - from FDA reports


Summary

95 females aged 34 (±5) who take the same drug are studied. This is a personalized study for a 34 year old female patient who has . The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Nov, 11, 2017

95 females aged 34 (±5) who take Rexulti are studied.


Number of reports submitted per year:

Rexulti for a 34-year old woman.

Information of the patient in this study:

  • Age: 34
  • Gender: female
  • Conditions:
  • Drugs taken:
    • Rexulti (brexpiprazole)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • weight increased
  • appetite - increased
  • abdominal distension
  • swollen tongue
  • akathisia
  • muscle twitching
  • libido increased
  • swallowing difficulty
  • gait disturbance
  • drooling
1 - 6 months:
  • weight increased
  • blood glucose increased
  • abdominal distension
  • body mass index increased
  • memory loss
  • hair loss
  • appetite - decreased
  • myositis
  • disturbance in attention
  • high blood pressure
6 - 12 months:
  • hyperprolactinaemia
  • galactorrhea
1 - 2 years:
  • nausea and vomiting
  • malaise
  • drowsiness
  • abdominal discomfort
  • headache
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • weight increased
  • agitation
  • depression
  • feeling abnormal
  • stress and anxiety
  • akathisia
  • headache
  • suicidal ideation
  • hypersensitivity
  • seizures

Top conditions involved for these people *:

  • Major Depression (29 people, 30.53%)
  • Depression (16 people, 16.84%)
  • Bipolar Disorder (12 people, 12.63%)
  • Stress And Anxiety (9 people, 9.47%)
  • Schizophrenia (6 people, 6.32%)

Top co-used drugs for these people *:

  • Lexapro (6 people, 6.32%)
  • Latuda (6 people, 6.32%)
  • Abilify (6 people, 6.32%)
  • Xanax (5 people, 5.26%)
  • Celexa (5 people, 5.26%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

Related studies:

Can you answer these questions?

More questions for: Rexulti

You may be interested in these reviews

More reviews for: Rexulti